Invention Grant
- Patent Title: Detection of a panel of urine DNA markers for HCC screening and disease management
-
Application No.: US14079649Application Date: 2013-11-14
-
Publication No.: US09598735B2Publication Date: 2017-03-21
- Inventor: Wei Song , Batbold Boldbaatar , Lijia Xie , Sitong Chen
- Applicant: JBS Science Inc.
- Applicant Address: unknown Doylestown
- Assignee: JBS Science Inc.
- Current Assignee: JBS Science Inc.
- Current Assignee Address: unknown Doylestown
- Agency: Syncoda, LLC
- Agent Junjie Feng
- Main IPC: C12Q1/68
- IPC: C12Q1/68

Abstract:
Provided herein is a method for detecting the presence or absence of a cancer in a biological sample of an individual, by determining the level of mutation and methylation of one or more genes from a group of genes comprising TP53, CTNNB1, hTERT, RASSF1A, GSTP1, p16, p15 and SFRP-1. Also provided herein is an assay to detect p53 mutations suitable for DNA isolated from biological body fluid in order to screen cancer patients.Also provided is a method for detecting the presence or absence of a liver cancer in an individual by determining the level of methylation.Also provided is a suitable method for detecting the presence or absence of a liver cancer in an individual by determining the level of methylation of the promoter of the GSTP1 gene in body fluid such as urine or blood.Also provided is a suitable method for detecting the presence or absence of a liver cancer in an individual by determining the level of methylation of the promoter of the RASSF1A gene in body fluid such as urine or blood.
Public/Granted literature
- US20140155279A1 Detection of a panel of urine DNA markers for HCC screening and disease management Public/Granted day:2014-06-05
Information query